Ignite Creation Date:
2024-10-25 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06538116
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-01
Brief Title:
A Study of Mevidalen LY3154207 in Participants With Alzheimers Disease
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Double-Blinded Study to Evaluate the Efficacy and Safety of Mevidalen in Patients With Alzheimers Disease
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main purpose of this study is to look at how safe the study drug mevidalen is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer Disease AD dementia This is done by looking at participants thinking and memory cognition everyday activities and sleep AD symptoms physical activity irritability or anxiety The study is expected to last approximately 26 weeks and may include up to 14 visits
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None